Detection of Fatal Diseases


Breathonix breath test solution provides 60 seconds detection with over 90% accuracy. 


Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis. 

Key Highlights

Slingshot 2019 MedTech Winner

Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition.

6+ years of breath analysis research

The technology is developed from 6+ years of breath analysis research in National University of Singapore (NUS).

Backed by reputable investors

Funded by NUS Enterprise and Antler.


To the ones who made it possible 

Join our mission

Reimagine medical test with Rapid Breath Test for Disease Detection

Latest Updates

As one of SWITCH’s MedTech Sector winner last year, Breathonix was invited to pitch at SFF X SWITCH 2020 hosted by Enterprise SG. In case you missed it, fret not you can still check out our summarise pitch deck in […]
Breathonix has developed a breath test to detect COVID-19 within a minute in-situ (on-site), achieving an accuracy above 90% at a recent pilot clinical trial involving 180 patients.
Following a successful trial at the National Centre for Infectious Diseases (NCID), the company said on Thursday (Oct 29) that it is currently in discussions with the Health Ministry (MOH) to deploy its breathalyser tests in trials at public locations in the coming months.